Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphatic Diseases × amonafide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphatic Diseases 1 Leukemia 1

Interventions

Cytarabine 2 ponatinib 1 ibrutinib 1 ibritumomab tiuxetan 1 cirmtuzumab 1 amonafide 1 Rituximab 1 Melphalan 1 Imatinib Mesylate 1 Etoposide 1 Daunorubicin 1 Carmustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00715637 2010-10-13

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Antisoma Research

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Lymphatic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡